(Total Views: 497)
Posted On: 04/01/2025 9:41:48 AM
Post# of 155828
TNBC - MOA and combination studies as pre-clinical.
By 48 month follow-up, we will have had the data for close to 1 year.
This time me says no FDA application/ approval of any kind for a while related to mTNBC.
Dr. J initially said potentially significant partner/and or approval. To potential partner/approval with possibly a funding raise. I combine that with Dr. Pestell going to 2nd conference in July --- my "May" or within weeks after, are very much lowered to doctor excitement talk.
Anything better would be outstanding --- just never seen FDA jump in @ pre-clinical combo MOA.
Why are we not filing a mono MOA Request based on our a Ladies of Leronlimab? Maybe they do...who knows
By 48 month follow-up, we will have had the data for close to 1 year.
This time me says no FDA application/ approval of any kind for a while related to mTNBC.
Dr. J initially said potentially significant partner/and or approval. To potential partner/approval with possibly a funding raise. I combine that with Dr. Pestell going to 2nd conference in July --- my "May" or within weeks after, are very much lowered to doctor excitement talk.
Anything better would be outstanding --- just never seen FDA jump in @ pre-clinical combo MOA.
Why are we not filing a mono MOA Request based on our a Ladies of Leronlimab? Maybe they do...who knows
(5)
(0)
